Gastric cancer: from biomarkers to functional precision medicine
Gastric cancer (GC) remains a deadly disease because of late detection and limited treatment options at advanced stages. Treatment of patients with metastatic disease is based on chemotherapy, complemented by antibodies targeting HER2, VEGFR2, and more recently PD-1 or claudin 18.2. Further targets,...
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
December 2025
|
| In: |
Trends in molecular medicine
Year: 2025, Volume: 31, Issue: 12, Pages: 1089-1102 |
| ISSN: | 1471-499X |
| DOI: | 10.1016/j.molmed.2025.05.007 |
| Online Access: | Verlag, kostenfrei, Volltext: https://doi.org/10.1016/j.molmed.2025.05.007 Verlag, kostenfrei, Volltext: https://www.sciencedirect.com/science/article/pii/S1471491425001182 
|
| Author Notes: | Philipp Albrecht, Ekin Karabati, Matthias P. Ebert, and Johannes Betge |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1948879174 | ||
| 003 | DE-627 | ||
| 005 | 20260121163411.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 260115s2025 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.molmed.2025.05.007 |2 doi | |
| 035 | |a (DE-627)1948879174 | ||
| 035 | |a (DE-599)KXP1948879174 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Albrecht, Philipp |d 1998- |e VerfasserIn |0 (DE-588)1387570706 |0 (DE-627)1949919358 |4 aut | |
| 245 | 1 | 0 | |a Gastric cancer |b from biomarkers to functional precision medicine |c Philipp Albrecht, Ekin Karabati, Matthias P. Ebert, and Johannes Betge |
| 264 | 1 | |c December 2025 | |
| 300 | |b Diagramme | ||
| 300 | |a 14 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Online verfügbar: 23. Juni 2025, Artikelversion: 3. Dezember 2025 | ||
| 500 | |a Gesehen am 15.01.2026 | ||
| 520 | |a Gastric cancer (GC) remains a deadly disease because of late detection and limited treatment options at advanced stages. Treatment of patients with metastatic disease is based on chemotherapy, complemented by antibodies targeting HER2, VEGFR2, and more recently PD-1 or claudin 18.2. Further targets, such as FGFR2b, as well as novel drug classes including antibody-drug conjugates (ADCs) and bispecific antibodies, are promising developments in GC treatment. Despite the failure of several targeted agents, the landscape of GC therapy is evolving rapidly, facilitated by umbrella or platform precision medicine trials. The integration of next-generation sequencing and other omics techniques into molecular tumor boards, as well as functional drug testing on patient-derived models, might bring us closer to personalized oncology and ultimately improve patient survival. | ||
| 650 | 4 | |a functional precision medicine | |
| 650 | 4 | |a gastroesophageal adenocarcinoma | |
| 650 | 4 | |a immunotherapy | |
| 650 | 4 | |a patient-derived organoids | |
| 650 | 4 | |a precision oncology | |
| 650 | 4 | |a targeted therapy | |
| 700 | 1 | |a Karabati, Ekin |d 2000- |e VerfasserIn |0 (DE-588)1386776750 |0 (DE-627)194887931X |4 aut | |
| 700 | 1 | |a Ebert, Matthias |d 1968- |e VerfasserIn |0 (DE-588)1030133522 |0 (DE-627)734827083 |0 (DE-576)377938432 |4 aut | |
| 700 | 1 | |a Betge, Johannes |d 1986- |e VerfasserIn |0 (DE-588)108257421X |0 (DE-627)847674347 |0 (DE-576)455525021 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Trends in molecular medicine |d Amsterdam [u.a.] : Elsevier Science, 2001 |g 31(2025), 12 vom: Dez., Seite 1089-1102 |h Online-Ressource |w (DE-627)391368036 |w (DE-600)2155736-6 |w (DE-576)252209338 |x 1471-499X |7 nnas |a Gastric cancer from biomarkers to functional precision medicine |
| 773 | 1 | 8 | |g volume:31 |g year:2025 |g number:12 |g month:12 |g pages:1089-1102 |g extent:14 |a Gastric cancer from biomarkers to functional precision medicine |
| 856 | 4 | 0 | |u https://doi.org/10.1016/j.molmed.2025.05.007 |x Verlag |x Resolving-System |z kostenfrei |3 Volltext |7 0 |
| 856 | 4 | 0 | |u https://www.sciencedirect.com/science/article/pii/S1471491425001182 |x Verlag |z kostenfrei |3 Volltext |7 0 |
| 951 | |a AR | ||
| 992 | |a 20260115 | ||
| 993 | |a Article | ||
| 994 | |a 2025 | ||
| 998 | |g 108257421X |a Betge, Johannes |m 108257421X:Betge, Johannes |d 60000 |d 61100 |e 60000PB108257421X |e 61100PB108257421X |k 0/60000/ |k 1/60000/61100/ |p 4 |y j | ||
| 998 | |g 1030133522 |a Ebert, Matthias |m 1030133522:Ebert, Matthias |d 60000 |d 61100 |e 60000PE1030133522 |e 61100PE1030133522 |k 0/60000/ |k 1/60000/61100/ |p 3 | ||
| 998 | |g 1386776750 |a Karabeti, Ekin |m 1386776750:Karabeti, Ekin |d 60000 |e 60000PK1386776750 |k 0/60000/ |p 2 | ||
| 998 | |g 1387570706 |a Albrecht, Philipp |m 1387570706:Albrecht, Philipp |d 140000 |e 140000PA1387570706 |k 0/140000/ |p 1 |x j | ||
| 999 | |a KXP-PPN1948879174 |e 4848976812 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"relHost":[{"title":[{"title":"Trends in molecular medicine","title_sort":"Trends in molecular medicine"}],"pubHistory":["7.2001 -"],"physDesc":[{"extent":"Online-Ressource"}],"language":["eng"],"note":["Gesehen am 21.11.23"],"type":{"media":"Online-Ressource","bibl":"periodical"},"part":{"extent":"14","text":"31(2025), 12 vom: Dez., Seite 1089-1102","pages":"1089-1102","volume":"31","year":"2025","issue":"12"},"origin":[{"dateIssuedKey":"2001","publisher":"Elsevier Science","dateIssuedDisp":"2001-","publisherPlace":"Amsterdam [u.a.]"}],"id":{"issn":["1471-499X"],"zdb":["2155736-6"],"eki":["391368036"]},"disp":"Gastric cancer from biomarkers to functional precision medicineTrends in molecular medicine","recId":"391368036"}],"note":["Online verfügbar: 23. Juni 2025, Artikelversion: 3. Dezember 2025","Gesehen am 15.01.2026"],"name":{"displayForm":["Philipp Albrecht, Ekin Karabati, Matthias P. Ebert, and Johannes Betge"]},"recId":"1948879174","id":{"doi":["10.1016/j.molmed.2025.05.007"],"eki":["1948879174"]},"origin":[{"dateIssuedDisp":"December 2025","dateIssuedKey":"2025"}],"physDesc":[{"extent":"14 S.","noteIll":"Diagramme"}],"language":["eng"],"type":{"bibl":"article-journal","media":"Online-Ressource"},"person":[{"display":"Albrecht, Philipp","given":"Philipp","role":"aut","family":"Albrecht"},{"family":"Karabati","role":"aut","given":"Ekin","display":"Karabati, Ekin"},{"family":"Ebert","given":"Matthias","role":"aut","display":"Ebert, Matthias"},{"display":"Betge, Johannes","given":"Johannes","role":"aut","family":"Betge"}],"title":[{"subtitle":"from biomarkers to functional precision medicine","title":"Gastric cancer","title_sort":"Gastric cancer"}]} | ||
| SRT | |a ALBRECHTPHGASTRICCAN2025 | ||